Compare
Albemarle Corp vs DuPont de Nemours, Inc. vs Avient Corp vs Eastman Chemical Co
| Latest fiscal year | Albemarle Corp ALB | DuPont de Nemours, Inc. DD | Avient Corp AVNT | Eastman Chemical Co EMN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $5.14B | $6.85B | $3.26B | $8.75B |
| Revenue growth (YoY) | -4.4% | +1.9% | +0.6% | -6.7% |
| Gross margin | 13.0% | n/a | 31.2% | 21.1% |
| Operating margin | -7.1% | n/a | 6.2% | n/a |
| Net margin | -9.9% | -11.4% | 2.5% | 5.4% |
| Net income | -$510.63M | -$779.00M | $81.90M | $474.00M |
| EPS (Diluted) | -$5.76 | -$1.86 | $0.89 | $4.10 |
| Operating cash flow | $1.28B | $560.00M | $301.60M | $970.00M |
| Free cash flow | $692.47M | $227.00M | $195.00M | $424.00M |
| Cash & equivalents | n/a | $715.00M | n/a | $566.00M |
| Total assets | $16.37B | $21.57B | $6.03B | $14.86B |
| Total liabilities | n/a | $7.47B | n/a | $8.82B |
| Shareholders' equity | $9.78B | $14.10B | $2.37B | $5.96B |
| Return on year-end equity | -5.2% | -5.5% | 3.4% | 8.0% |
| Shares outstanding | 117.72M | n/a | n/a | 223.94M |
Revenue, most recent five fiscal years
| Fiscal year | Albemarle Corp | DuPont de Nemours, Inc. | Avient Corp | Eastman Chemical Co |
|---|---|---|---|---|
| Latest | $5.14B Ended 2025-12-31 | $6.85B Ended 2025-12-31 | $3.26B Ended 2025-12-31 | $8.75B Ended 2025-12-31 |
| 1 year earlier | $5.38B Ended 2024-12-31 | $6.72B Ended 2024-12-31 | $3.24B Ended 2024-12-31 | $9.38B Ended 2024-12-31 |
| 2 years earlier | $9.62B Ended 2023-12-31 | $6.61B Ended 2023-12-31 | $3.14B Ended 2023-12-31 | $9.21B Ended 2023-12-31 |
| 3 years earlier | $7.32B Ended 2022-12-31 | $13.02B Ended 2022-12-31 | $3.40B Ended 2022-12-31 | $10.58B Ended 2022-12-31 |
| 4 years earlier | $3.33B Ended 2021-12-31 | $12.57B Ended 2021-12-31 | $3.32B Ended 2021-12-31 | $10.48B Ended 2021-12-31 |